Souheil El‐Chemaly

AVEO Oncology (United States) — United States

Medicine · Health Sciences

39h-index4.7kcitations177works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(47), Transplantation: Methods and Outcomes(43), Tuberous Sclerosis Complex Research(38), Medical Imaging and Pathology Studies(20), Vascular Tumors and Angiosarcomas(16)

Publications177 total

Belumosudil in diffuse cutaneous systemic sclerosis: a randomized, double-blind, open-label extension, placebo-controlled, phase 2 study
Lara D. Veeken·2025· 3 citedOpen Access
A Comparison of Clinical and Radiological Presentations of Sporadic and Tuberous Sclerosis Complex‐Associated Lymphangioleiomyomatosis
American Journal of Medical Genetics Part A·2024· 1 cited
Carbon monoxide-induced autophagy enhances human mesenchymal stromal cell function via paracrine actions in murine polymicrobial sepsis
Molecular Therapy·2024· 14 citedOpen Access
Leveraging Blood-based Transcriptomics to Detect Acute Cellular Rejection in Lung Transplant
2024
Leveraging blood-based transcriptomics to detect acute cellular rejection in lung transplant
JHLT Open·2024· 1 citedOpen Access
Limited Effect of Prevention Strategies on Incidence of Clinically Detectable Venous Thromboembolism After Lung Transplantation
Transplantation Proceedings·2023· 1 cited
Lymphangioleiomyomatosis: circulating levels of FGF23 and pulmonary diffusion
Jornal Brasileiro de Pneumologia·2023· 5 citedOpen Access
Data from [<sup>18</sup>F]Fluorocholine and [<sup>18</sup>F]Fluoroacetate PET as Imaging Biomarkers to Assess Phosphatidylcholine and Mitochondrial Metabolism in Preclinical Models of TSC and LAM
2023Open Access
Figure S1 from [<sup>18</sup>F]Fluorocholine and [<sup>18</sup>F]Fluoroacetate PET as Imaging Biomarkers to Assess Phosphatidylcholine and Mitochondrial Metabolism in Preclinical Models of TSC and LAM
2023Open Access
Figure S3 from [<sup>18</sup>F]Fluorocholine and [<sup>18</sup>F]Fluoroacetate PET as Imaging Biomarkers to Assess Phosphatidylcholine and Mitochondrial Metabolism in Preclinical Models of TSC and LAM
2023Open Access
Supplementary Materials and Methods, Supplementary Figures 1 through 3 and Supplementary Tables 1 through 5 from Aberrant SYK Kinase Signaling Is Essential for Tumorigenesis Induced by TSC2 Inactivation
2023Open Access
Data from [<sup>18</sup>F]Fluorocholine and [<sup>18</sup>F]Fluoroacetate PET as Imaging Biomarkers to Assess Phosphatidylcholine and Mitochondrial Metabolism in Preclinical Models of TSC and LAM
2023Open Access
Data from Aberrant SYK Kinase Signaling Is Essential for Tumorigenesis Induced by TSC2 Inactivation
2023Open Access
Figure S2 from [<sup>18</sup>F]Fluorocholine and [<sup>18</sup>F]Fluoroacetate PET as Imaging Biomarkers to Assess Phosphatidylcholine and Mitochondrial Metabolism in Preclinical Models of TSC and LAM
2023Open Access
Figure S4 from [<sup>18</sup>F]Fluorocholine and [<sup>18</sup>F]Fluoroacetate PET as Imaging Biomarkers to Assess Phosphatidylcholine and Mitochondrial Metabolism in Preclinical Models of TSC and LAM
2023Open Access
Figure S4 from [<sup>18</sup>F]Fluorocholine and [<sup>18</sup>F]Fluoroacetate PET as Imaging Biomarkers to Assess Phosphatidylcholine and Mitochondrial Metabolism in Preclinical Models of TSC and LAM
2023Open Access
Supplementary text from [<sup>18</sup>F]Fluorocholine and [<sup>18</sup>F]Fluoroacetate PET as Imaging Biomarkers to Assess Phosphatidylcholine and Mitochondrial Metabolism in Preclinical Models of TSC and LAM
2023Open Access
Figure S5 from [<sup>18</sup>F]Fluorocholine and [<sup>18</sup>F]Fluoroacetate PET as Imaging Biomarkers to Assess Phosphatidylcholine and Mitochondrial Metabolism in Preclinical Models of TSC and LAM
2023Open Access
Figure S1 from [<sup>18</sup>F]Fluorocholine and [<sup>18</sup>F]Fluoroacetate PET as Imaging Biomarkers to Assess Phosphatidylcholine and Mitochondrial Metabolism in Preclinical Models of TSC and LAM
2023Open Access
Figure S2 from [<sup>18</sup>F]Fluorocholine and [<sup>18</sup>F]Fluoroacetate PET as Imaging Biomarkers to Assess Phosphatidylcholine and Mitochondrial Metabolism in Preclinical Models of TSC and LAM
2023Open Access
page 1 of 9Next →

Frequent Co-authors

Iván O. Rosas(24), Hilary J. Goldberg(16), Gary M. Hunninghake(11), Joel Moss(9), Sarah Chu(7), Julian A. Villalba(7), George R. Washko(6), Benjamin A. Raby(6), Ye Cui(6), Rachel K. Putman(5), Hiroto Hatabu(5), Bernadette R. Gochuico(5), Andrew Courtwright(5), Mizuki Nishino(4), Juan C. Osorio(4), Augustine M.K. Choi(4), Gustavo Pacheco–Rodriguez(4), Konstantin Tsoyi(4), Sergio Poli(4), Elizabeth P. Henske(4)